196 related articles for article (PubMed ID: 17266182)
21. Rapid and sensitive p53 alteration analysis in biopsies from lung cancer patients using a functional assay and a universal oligonucleotide array: a prospective study.
Fouquet C; Antoine M; Tisserand P; Favis R; Wislez M; Commo F; Rabbe N; Carette MF; Milleron B; Barany F; Cadranel J; Zalcman G; Soussi T
Clin Cancer Res; 2004 May; 10(10):3479-89. PubMed ID: 15161705
[TBL] [Abstract][Full Text] [Related]
22. Two functional assays employed to detect an unusual mutation in the oligomerisation domain of p53 in a Li-Fraumeni like family.
Lomax ME; Barnes DM; Gilchrist R; Picksley SM; Varley JM; Camplejohn RS
Oncogene; 1997 Apr; 14(15):1869-74. PubMed ID: 9150393
[TBL] [Abstract][Full Text] [Related]
23. Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry.
Jackson PE; Qian GS; Friesen MD; Zhu YR; Lu P; Wang JB; Wu Y; Kensler TW; Vogelstein B; Groopman JD
Cancer Res; 2001 Jan; 61(1):33-5. PubMed ID: 11196182
[TBL] [Abstract][Full Text] [Related]
24. Correlation of immunohistochemical staining and mutations of p53 in human hepatocellular carcinoma.
Hsia CC; Nakashima Y; Thorgeirsson SS; Harris CC; Minemura M; Momosaki S; Wang NJ; Tabor E
Oncol Rep; 2000; 7(2):353-6. PubMed ID: 10671685
[TBL] [Abstract][Full Text] [Related]
25. Selective detection of inactivating mutations of the tumor suppressor gene p53 in bladder tumors.
Pfister C; Flaman JM; Martin C; Grise P; Frebourg T
J Urol; 1999 Jun; 161(6):1973-5. PubMed ID: 10332483
[TBL] [Abstract][Full Text] [Related]
26. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines.
Liu Y; Bodmer WF
Proc Natl Acad Sci U S A; 2006 Jan; 103(4):976-81. PubMed ID: 16418264
[TBL] [Abstract][Full Text] [Related]
27. [A candidate tumor suppressor gene mutated in primary hepatocellular carcinoma: kruppel-like factor 6].
Wang SP; Chen XP; Qiu FZ
Zhonghua Wai Ke Za Zhi; 2004 Oct; 42(20):1258-61. PubMed ID: 15598377
[TBL] [Abstract][Full Text] [Related]
28. Detection of hotspot mutations and polymorphisms using an enhanced PCR-RFLP approach.
Liu WH; Kaur M; Makrigiorgos GM
Hum Mutat; 2003 May; 21(5):535-41. PubMed ID: 12673796
[TBL] [Abstract][Full Text] [Related]
29. Acetaldehyde-induced mutational pattern in the tumour suppressor gene TP53 analysed by use of a functional assay, the FASAY (functional analysis of separated alleles in yeast).
Paget V; Lechevrel M; Sichel F
Mutat Res; 2008 Mar; 652(1):12-9. PubMed ID: 18242117
[TBL] [Abstract][Full Text] [Related]
30. Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China.
Su H; Zhao J; Xiong Y; Xu T; Zhou F; Yuan Y; Zhang Y; Zhuang SM
Mutat Res; 2008 May; 641(1-2):27-35. PubMed ID: 18358501
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of yeast functional assay to detect p53 gene mutation in minute endoscopic samples of colonic mucosal neoplasia].
Nakamura Y
Hokkaido Igaku Zasshi; 1998 Sep; 73(5):505-17. PubMed ID: 9846280
[TBL] [Abstract][Full Text] [Related]
32. [Characteristics of high frequency 249 codon mutation of p53 gene in hepatocellular carcinoma in prevalent area of China].
Ming L; Yuan B; Thorgeirsson SS
Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):122-4. PubMed ID: 11776852
[TBL] [Abstract][Full Text] [Related]
33. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.
Hussain SP; Schwank J; Staib F; Wang XW; Harris CC
Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425
[TBL] [Abstract][Full Text] [Related]
34. [Establishment of mouse p53 yeast functional assay and evaluation of its detectability of p53 gene mutation].
Tsunematsu I
Hokkaido Igaku Zasshi; 1999 Jul; 74(4):301-14. PubMed ID: 10480037
[TBL] [Abstract][Full Text] [Related]
35. Mutation scanning of the p53 tumor suppressor gene in renal and liver transplant patients in Hungary.
Sarvary E; Nagy P; Benjamin A; Szoke M; Remport A; Jansen J; Nemes B; Kobori L; Fehervari I; Sulyok B; Perner F; Varga M; Fazakas J; Lakatos M; Szabo M; Toth A; Járay J
Transplant Proc; 2005 Mar; 37(2):969-72. PubMed ID: 15848594
[TBL] [Abstract][Full Text] [Related]
36. Distribution of p53 mutations in esophageal and gastric carcinomas and the relationship with p53 expression.
Hanazono K; Natsugoe S; Stein HJ; Aikou T; Hoefler H; Siewert JR
Oncol Rep; 2006 Apr; 15(4):821-4. PubMed ID: 16525665
[TBL] [Abstract][Full Text] [Related]
37. Splice mutations in the p53 gene: case report and review of the literature.
Holmila R; Fouquet C; Cadranel J; Zalcman G; Soussi T
Hum Mutat; 2003 Jan; 21(1):101-2. PubMed ID: 12497643
[TBL] [Abstract][Full Text] [Related]
38. bcl 10 gene mutation in hepatocellular carcinoma.
Cheng J; Leng X; Cai S; Cao Z; Cao G; Peng J; Wang S; Du R
Chin Med J (Engl); 2001 Jul; 114(7):747-51. PubMed ID: 11780342
[TBL] [Abstract][Full Text] [Related]
39. Characterization of germline TP53 splicing mutations and their genetic and functional analysis.
Varley JM; Attwooll C; White G; McGown G; Thorncroft M; Kelsey AM; Greaves M; Boyle J; Birch JM
Oncogene; 2001 May; 20(21):2647-54. PubMed ID: 11420676
[TBL] [Abstract][Full Text] [Related]
40. [Functional screening of p53 status in tumor cells using Saccharomyces cerevisiae].
Jia LQ; Ishioka C; Osada M; Gamo M; Shimodaira H; Suzuki T; Kanamaru R
Gan To Kagaku Ryoho; 1997 Feb; 24(4):466-70. PubMed ID: 9063485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
